Insurers Recommend CMS Expand Copay Accumulators To All Drugs

By Ariel Cohen / January 13, 2020 at 2:07 PM
Blue Cross Blue Shield Association and America’s Health Insurance Plans are urging CMS to update its copay accumulators policy to let exchange plans exclude drug makers’ copay coupons from counting toward enrollees’ out-of-pocket maximums for all drugs, not just for drugs where generic equivalents are available. The insurers also request CMS make it easier to track drug manufacturers’ and pharmacies’ use of financial assistance, such as co-pay coupons. The requests were made during a November meeting the insurers had with...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.